Star Therapeutics raises $200 million to build new drug pipeline after Vega and Electra wins
read at Endpoints ↗DealPositive
Star Therapeutics announced it has secured $200 million in financing.
The capital will be used to develop its own pipeline of medicines, aiming to replicate the success of its earlier Vega and Electra programs that were commercialized elsewhere.
CEO Adam Rosenthal said the funding represents a fresh start for the company's internal research efforts.
The investment highlights investor confidence in the company's ability to generate novel therapeutics.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Star Therapeutics gets $200M to try repeating its Vega, Electra successes”
read at Endpoints ↗87 words · retrieved 1h ago
comments(0)
5-min edit window · permanent after that